New York State Common Retirement Fund’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

New York State Common Retirement Fund’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300	Closed	-$543	–	3440
2023 Q2	$543	Sell	300 -23,200	-99%	-$42.4K	﹤0.01%	3358
2023 Q1	$31K	Hold	23,500	–	–	﹤0.01%	3068
2022 Q4	$39.7K	Hold	23,500	–	–	﹤0.01%	3122
2022 Q3	$43K	Buy	23,500 +300	+1%	+$895	﹤0.01%	3161
2022 Q2	$71K	Buy	+23,200	New	+$142K	﹤0.01%	3177

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

New York State Common Retirement Fund's PRDS Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 300 shares — an estimated $543 sold.

New York State Common Retirement Fund first reported a position in PRDS in Q2 2022 and held it in 5 quarters. The position peaked at $71K in Q2 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

New York State Common Retirement Fund reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 300 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $543.
New York State Common Retirement Fund first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
New York State Common Retirement Fund's Pardes Biosciences, Inc. Common Stock position peaked at $71K in Q2 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.